STAT+: Drug companies will have to start refunding Medicare for certain drugs that get thrown out

Starting in 2023, Medicare will be refunded for the unused portions of injectable and infused drugs administered by physicians in outpatient clinics.

Starting next year, pharmaceutical companies will have to repay Medicare for any unused amount of drugs that come in single-dose vials.

The mandate was tucked inside the bipartisan infrastructure bill passed last year, and on Thursday Medicare implemented this new provision as part of its broader annual rule that updates physician payments for 2023.

Continue to STAT+ to read the full story…